139 related articles for article (PubMed ID: 38733371)
41. The extracellular hemoglobin of the earthworm, Lumbricus terrestris. Oxygenation properties of isolated chains, trimer, and a reassociated product.
Fushitani K; Riggs AF
J Biol Chem; 1991 Jun; 266(16):10275-81. PubMed ID: 2037579
[TBL] [Abstract][Full Text] [Related]
42. Engineering tyrosine residues into hemoglobin enhances heme reduction, decreases oxidative stress and increases vascular retention of a hemoglobin based blood substitute.
Cooper CE; Silkstone GGA; Simons M; Rajagopal B; Syrett N; Shaik T; Gretton S; Welbourn E; Bülow L; Eriksson NL; Ronda L; Mozzarelli A; Eke A; Mathe D; Reeder BJ
Free Radic Biol Med; 2019 Apr; 134():106-118. PubMed ID: 30594736
[TBL] [Abstract][Full Text] [Related]
43. A novel cross-linked haemoglobin-based oxygen carrier is beneficial to sepsis in rats.
Kuang L; Zhu Y; Zhang J; Wu Y; Tian K; Chen X; Xue M; Tzang FC; Lau B; Wong BL; Liu L; Li T
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1496-1504. PubMed ID: 30983419
[TBL] [Abstract][Full Text] [Related]
44. Subunit distribution of calcium-binding sites in Lumbricus terrestris hemoglobin.
Kuchumov AR; Loo JA; Vinogradov SN
J Protein Chem; 2000 Feb; 19(2):139-49. PubMed ID: 10945438
[TBL] [Abstract][Full Text] [Related]
45. Lumbricus erythrocruorin at 3.5 A resolution: architecture of a megadalton respiratory complex.
Royer WE; Sharma H; Strand K; Knapp JE; Bhyravbhatla B
Structure; 2006 Jul; 14(7):1167-77. PubMed ID: 16843898
[TBL] [Abstract][Full Text] [Related]
46. Kinetic studies on oxygen releasing of HBOC and red blood cells as fluids and factors affecting the process.
Zhao B; Zhang S; Meng Z; Wang D; Li Q; Guo Y; Li F; Wang X; Yang C
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1076-S1082. PubMed ID: 30449264
[TBL] [Abstract][Full Text] [Related]
47. O-raffinose-polymerised haemoglobin. A biochemical and pharmacological profile of an oxygen carrier.
Scatena R; Giardina B
Expert Opin Biol Ther; 2001 Jan; 1(1):121-7. PubMed ID: 11727541
[TBL] [Abstract][Full Text] [Related]
48. Molecular shape, dissociation, and oxygen binding of the dodecamer subunit of Lumbricus terrestris hemoglobin.
Krebs A; Kuchumov AR; Sharma PK; Braswell EH; Zipper P; Weber RE; Chottard G; Vinogradov SN
J Biol Chem; 1996 Aug; 271(31):18695-704. PubMed ID: 8702524
[TBL] [Abstract][Full Text] [Related]
49. Processing of ferulic acid modified hemoglobin.
Guo S; Wang P; Chen C; Meng Z; Qi D; Wang X
Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1075-9. PubMed ID: 26838267
[TBL] [Abstract][Full Text] [Related]
50. Absence of ligand binding-induced tertiary changes in the multimeric earthworm Lumbricus terrestris hemoglobin. A resonance Raman study.
Vidugiris GJ; Harrington JP; Friedman JM; Hirsch RE
J Biol Chem; 1993 Dec; 268(35):26190-2. PubMed ID: 8253738
[TBL] [Abstract][Full Text] [Related]
51. Synthesis of bioactive hemoglobin-based oxygen carrier nanoparticles via metal-phenolic complexation.
Nadimifar M; Jin W; Coll-Satue C; Bor G; Kempen PJ; Moosavi-Movahedi AA; Hosta-Rigau L
Biomater Adv; 2024 Jan; 156():213698. PubMed ID: 38006785
[TBL] [Abstract][Full Text] [Related]
52. Comprehensive Biochemical and Biophysical Characterization of Hemoglobin-Based Oxygen Carrier Therapeutics: All HBOCs Are Not Created Equally.
Meng F; Kassa T; Jana S; Wood F; Zhang X; Jia Y; D'Agnillo F; Alayash AI
Bioconjug Chem; 2018 May; 29(5):1560-1575. PubMed ID: 29570272
[TBL] [Abstract][Full Text] [Related]
53. Application of HBOCs electrophoretic method to detect a new blood substitute derived from the giant extracellular haemoglobin of lugworm.
Marchand A; Crepin N; Roulland I; Semence F; Domergue V; Zal F; Polard V; Coquerel A
Drug Test Anal; 2017 Nov; 9(11-12):1762-1767. PubMed ID: 27787946
[TBL] [Abstract][Full Text] [Related]
54. Tangential flow filtration facilitated fractionation and PEGylation of low and high-molecular weight polymerized hemoglobins and their biophysical properties.
Gu X; Savla C; Palmer AF
Biotechnol Bioeng; 2022 Jan; 119(1):176-186. PubMed ID: 34672363
[TBL] [Abstract][Full Text] [Related]
55. Design of recombinant hemoglobins for use in transfusion fluids.
Fronticelli C; Koehler RC
Crit Care Clin; 2009 Apr; 25(2):357-71, Table of Contents. PubMed ID: 19341913
[TBL] [Abstract][Full Text] [Related]
56. Site-specific cross-linking of human and bovine hemoglobins differentially alters oxygen binding and redox side reactions producing rhombic heme and heme degradation.
Nagababu E; Ramasamy S; Rifkind JM; Jia Y; Alayash AI
Biochemistry; 2002 Jun; 41(23):7407-15. PubMed ID: 12044174
[TBL] [Abstract][Full Text] [Related]
57. [Modified hemoglobins as oxygen transporting blood substitutes ].
Waschke KF
Anaesthesist; 1995 Jan; 44(1):1-12. PubMed ID: 7695075
[TBL] [Abstract][Full Text] [Related]
58. Lack of size and shape alteration of oxygenated and deoxygenated Lumbricus terrestris hemoglobin?
Krebs A; Zipper P; Vinogradov SN
Biochim Biophys Acta; 1996 Oct; 1297(2):115-8. PubMed ID: 8917610
[TBL] [Abstract][Full Text] [Related]
59. [Autologous transfusion - from euphoria to reason: clinical practice based on scientific knowledge. (Part IV). Artificial oxygen carriers: cell-free hemoglobin solutions -- current status 2004].
Standl T
Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Jan; 40(1):38-45. PubMed ID: 15645386
[TBL] [Abstract][Full Text] [Related]
60. Hemoglobin-based Oxygen Carriers: Current State-of-the-art and Novel Molecules.
Sen Gupta A
Shock; 2019 Oct; 52(1S Suppl 1):70-83. PubMed ID: 31513123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
